| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Ali Ph.D. Fattaey last filed a Form 4 in May 2018, as President & CEO at CRIS. Ali Ph.D. Fattaey's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 322,140 shares of CRIS. Net of sales, the CRIS filings show accumulation of 50,000 shares.
Ali Ph.D. Fattaey has 7 Form 4 filings on record from January 2015 to May 2018, all as President & CEO at Curis (CRIS), 2015–2018.
The 7 reported transactions were 5 option or other derivative awards, 1 stock award and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $53K and no sales.
The only open-market purchase was 50,000 shares of CRIS at an average $1.06 on November 15, 2017, about $53K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2017 | CRIS Curis Inc | President & CEO | Buy | 50,000 | $1.06 | $53,000.00 | +75.9% |